CLINICAL GENITOURINARY CANCER, vol.14, no.4, 2016 (Journal Indexed in SCI)
Article / Article
Title of Journal :
CLINICAL GENITOURINARY CANCER
Survival outcomes of interferon-alfa and tyrosine kinase inhibitors for 104 cases of metastatic renal cell carcinoma were included in this study. First-line interferon-alfa treatment before tyrosine kinase inhibitors had an additive survival affect.